Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Kura Oncology Inc.

    NASDAQ: KURA · Real-Time Price · USD
    7.68
    1.08 (16.36%)
    At close: Aug 15, 2025, 12:27 PM

    Kura Oncology Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 53.88M n/a n/a n/a
    Cost of Revenue
    		 848K 849K 759K 558K
    Gross Profit
    		 53.03M -849K -759K -558K
    Operating Income
    		 -193.19M -165.8M -139.87M -131.82M
    Interest Income
    		 22.85M 14.72M 4.25M 1.21M
    Pretax Income
    		 -171.97M -152.63M -135.84M -130.47M
    Net Income
    		 -173.98M -152.63M -136.07M -129.91M
    Selling & General & Admin
    		 77.11M 50.57M 47.05M 46.54M
    Research & Development
    		 169.97M 115.23M 92.81M 84.72M
    Other Expenses
    		 n/a -849K n/a n/a
    Operating Expenses
    		 247.08M 164.96M 139.87M 131.26M
    Interest Expense
    		 1.62M 1.55M 229K 414K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 247.08M 165.8M 139.87M 131.26M
    Income Tax Expense
    		 2.02M n/a 229K -558K
    Shares Outstanding (Basic)
    		 86.16M 73.23M 66.99M 66.35M
    Shares Outstanding (Diluted)
    		 86.16M 73.23M 66.99M 66.35M
    EPS (Basic)
    		 -2.02 -2.08 -2.03 -1.97
    EPS (Diluted)
    		 -2.02 -2.08 -2.03 -1.97
    EBITDA
    		 -169.5M -164.96M -134.85M -129.71M
    EBIT
    		 -170.35M -165.8M -135.61M -130.26M
    Depreciation & Amortization
    		 848K 849K 759K 558K

    Add to Watchlist